Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
2013-01-01–present
Recorded roles and earnings-call appearances connecting this person to public companies.
CEO, Board Member
2013-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Matinas BioPharma Holdings, Inc. (MTNB) | CEO | $598,000 | $598,000 |
| 2023 | Matinas BioPharma Holdings, Inc. (MTNB) | CEO | $598,000 | $1,599,551 |
| 2022 | Matinas BioPharma Holdings, Inc. (MTNB) | CEO | $575,000 | $1,674,207 |
| 2021 | Matinas BioPharma Holdings, Inc. (MTNB) | CEO | $545,000 | $3,693,314 |
| 2020 | Matinas BioPharma Holdings, Inc. (MTNB) | CEO | $500,000 | $2,930,085 |
| 2019 | Matinas BioPharma Holdings, Inc. (MTNB) | CEO | $444,792 | $1,325,176 |
| 2018 | Matinas BioPharma Holdings, Inc. (MTNB) | CEO | $366,458 | $1,254,727 |
Earnings-call appearances and filed executive appointments or departures, newest first.
